NCT04487314 Registry for Chronic Venous Disease Incidence and Natural Course
| NCT ID | NCT04487314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Russian Phlebological Association |
| Condition | Varicose Veins of Lower Limb |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2020-08-20 |
| Primary Completion | 2050-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2020-08-20 with a primary completion date of 2050-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective cohort study of patients with primary varicose veins to assess the morbidity, risk factors and development of chronic lower limb vein disease.
Eligibility Criteria
Inclusion Criteria: * A family members of the researcher (spouse, childrens, brothers and sisters, parents) or the researcher himself * The possibility of annual clinical and ultrasound assessment of the venous system of the observed individuals Exclusion Criteria: * Any invasive treatment of the chronic venous disorder in anamnesis * Venous thrombosis in the anamnesis or at the time of inclusion
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04487314 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, studying Varicose Veins of Lower Limb. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04487314 currently recruiting?
Yes, NCT04487314 is actively recruiting participants. Contact the research team at evgeny@ilyukhin.info for enrollment information.
Where is the NCT04487314 trial being conducted?
This trial is being conducted at Saint Petersburg, Russia.
Who is sponsoring the NCT04487314 clinical trial?
NCT04487314 is sponsored by Russian Phlebological Association. The trial plans to enroll 10,000 participants.